Bailard’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Buy |
10,703
+580
| +6% | +$70.2K | 0.03% | 291 |
|
|
2025
Q1 | $1.13M | Buy |
10,123
+4,160
| +70% | +$464K | 0.03% | 290 |
|
|
2024
Q4 | $580K | Buy |
5,963
+283
| +5% | +$27.5K | 0.01% | 431 |
|
|
2024
Q3 | $653K | Buy |
5,680
+1,593
| +39% | +$183K | 0.02% | 414 |
|
|
2024
Q2 | $435K | Buy |
4,087
+661
| +19% | +$70.4K | 0.01% | 479 |
|
|
2024
Q1 | $331K | Buy |
+3,426
| New | +$331K | 0.01% | 542 |
|
|
2021
Q1 | – | Sell |
-9,088
| Closed | -$858K | – | 727 |
|
|
2020
Q4 | $858K | Buy |
9,088
+550
| +6% | +$51.9K | 0.04% | 235 |
|
|
2020
Q3 | $742K | Buy |
8,538
+485
| +6% | +$42.1K | 0.04% | 234 |
|
|
2020
Q2 | $703K | Buy |
8,053
+3,102
| +63% | +$271K | 0.04% | 225 |
|
|
2020
Q1 | $408K | Sell |
4,951
-956
| -16% | -$78.8K | 0.03% | 258 |
|
|
2019
Q4 | $559K | Sell |
5,907
-33
| -0.6% | -$3.12K | 0.03% | 257 |
|
|
2019
Q3 | $516K | Buy |
5,940
+600
| +11% | +$52.1K | 0.03% | 263 |
|
|
2019
Q2 | $487K | Buy |
5,340
+172
| +3% | +$15.7K | 0.03% | 290 |
|
|
2019
Q1 | $446K | Buy |
+5,168
| New | +$446K | 0.03% | 324 |
|